DICE Therapeutics OverviewDICE Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for DICE.
Quarterly EBIT
-$34.82M
↓ 60.12% YoY
As of Jun 30, 2023
Annual EBIT (TTM)
-$114.01M
↓ 56.87% YoY
Trailing 12 months ending Jun 30, 2023
DICE Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for DICE.
As of Jun 30, 2023
Trailing 12 months ending Jun 30, 2023